Vascepa, a prescription omega-3 fatty acid, is effective in reducing heart disease risk. The medication reduces inflammation and has helped reduce major adverse cardiovascular events by 25% in patients with high triglycerides and established cardiovascular disease, according to the REDUCE-IT trial. Other studies also found Vascepa reduced the risk of cardiovascular events by 18%. The average cost of Vascepa is around $250 per month.
FIN7 Deploys Anubis Backdoor to Hijack Windows Systems via Compromised SharePoint Sites
The Russian cybercrime group FIN7 is linked to a Python-based backdoor named Anubis, providing them remote access to compromised Windows systems, says Swiss cybersecurity firm
